Burns: Where Are We Standing With Propranolol, Oxandrolone, Recombinant Human Growth Hormone, and the New Incretin Analogs?

Current Opinion in Clinical Nutrition and Metabolic Care - United States
doi 10.1097/mco.0b013e3283428df1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Adolescent Friendly Health Services: Where Are We Actually Standing?

International Journal Of Community Medicine And Public Health
2017English

The New Handshake: Where We Are Now

International Journal on Online Dispute Resolution
2016English

Animal Sentience: Where Are We and Where Are We Heading?

Animals
Animal ScienceZoologyVeterinary
2012English

Diagnosis of Alzheimers Disease From EEG Signals: Where Are We Standing?

Current Alzheimer Research
Neurology
2010English

Sequence Analysis: Where Are We, Where Are We Going?

Sequence Analysis and Related Approaches
2018English

Molecular Targeted Agents--Where We Are and Where We Are Going

Chinese Journal of Cancer
2013English

Antisperm Contraceptive Vaccines: Where We Are and Where We Are Going?

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2011English

Pulmonary Arterial Hypertension: Where Are We and Where Are We Going?

Advances in Pulmonary Hypertension
2009English

Understanding Diabetic Teratogenesis: Where Are We Now and Where Are We Going?

Birth Defects Research Part A - Clinical and Molecular Teratology
Child HealthPediatricsPerinatologyMedicineDevelopmental BiologyEmbryology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy